Compare Axogen Inc (AXGN) vs ProShares Ultra QQQ ETF (QLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Axogen Inc vs ProShares Ultra QQQ ETF — how do they compare? Axogen Inc trades at $39.4 (market cap $2.06B), while ProShares Ultra QQQ ETF trades at $93.24. Which is the better fit depends on your goals.
| AXGN | QLD | |
|---|---|---|
Market Cap | $2.06B | — |
Sector | Technology | Leveraged / Inverse |
52-Week High | $46.19 | $100.53 |
52-Week Low | $11.28 | $57.16 |
Enterprise Value | $1.98B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
QLD, the ProShares Ultra QQQ ETF, trades at $90.13, down 3.81% over 24 hours, reflecting a bearish technical signal with key support at $87. As a 2x daily leveraged ETF tracking the Nasdaq-100, it offers amplified exposure to large-cap tech stocks but carries inherent volatility risks. Recent news highlights its long-term performance, with over 10,000% total return since inception, though comparisons with 3x leveraged alternatives underscore drawdown vulnerabilities.
The outlook for QLD hinges on Nasdaq-100 momentum, with tech earnings and AI optimism as potential catalysts. However, leveraged decay and market volatility pose significant risks, making it suitable only for tactical, risk-tolerant investors. Current neutral oscillators suggest near-term consolidation, but bearish moving averages indicate downward pressure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Axogen Inc
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →About ProShares Ultra QQQ ETF
QLD is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the NASDAQ-100 Index. It achieves 2x leverage by investing in financial instruments such as swaps and is designed as a tactical trading tool for investors with a bullish (long) view on the NASDAQ-100. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on QLD →
